Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citius Pharmaceuticals Inc (CTXR) vs Northrop Grumman Corporation (NOC) Price & Performance

Citius Pharmaceuticals IncTrade
Northrop Grumman CorporationTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs Northrop Grumman Corporation — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Northrop Grumman Corporation trades at $574.85 (market cap $81.78B). The key difference: Northrop Grumman Corporation is far larger — about 4087× Citius Pharmaceuticals Inc's market cap, and Northrop Grumman Corporation pays a 1.63% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

CTXRNOC
Market Cap
$20.01M$81.78B
Sector
HealthIndustrials
52-Week High
$1.82$768.02
52-Week Low
$0.48$496.02
Enterprise Value
$16.23M$95.77B
Dividend Yield
1.63%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC